McCarthy Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

McCarthy Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-597	Closed	-$54K	–	307
2022 Q1	$54K	Hold	597	–	–	0.04%	74
2021 Q4	$67K	Hold	597	–	–	0.05%	70
2021 Q3	$75K	Hold	597	–	–	0.06%	66
2021 Q2	$81K	Hold	597	–	–	0.06%	69
2021 Q1	$81K	Hold	597	–	–	0.06%	68
2020 Q4	$84K	Buy	+597	New	+$76.5K	0.07%	64

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

McCarthy Asset Management's XBI Position: Q2 2022 in Review

McCarthy Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 597 shares — an estimated $54K sold.

McCarthy Asset Management first reported a position in XBI in Q4 2020 and held it in 6 quarters. The position peaked at $84K in Q4 2020. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

McCarthy Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
McCarthy Asset Management sold 597 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $54K.
McCarthy Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 6 quarters.
McCarthy Asset Management's State Street SPDR S&P Biotech ETF position peaked at $84K in Q4 2020.
706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.